ab40868 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab40868 は 8 報の論文で使用されています。

  • Karmakar S  et al. Interaction of glucocorticoid receptor (GR) with estrogen receptor (ER) a and activator protein 1 (AP1) in dexamethasone-mediated interference of ERa activity. J Biol Chem 288:24020-34 (2013). WB, IP ; Human . PubMed: 23814048
  • Habashy HO  et al. FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer. Breast Cancer Res Treat 129:11-21 (2011). IHC-P ; Human . PubMed: 21336599
  • Habashy HO  et al. RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype. Breast Cancer Res Treat 128:315-26 (2011). IHC-P ; Human . PubMed: 20697807
  • Rakha EA  et al. Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes. Clin Cancer Res 15:2302-10 (2009). Human . PubMed: 19318481
  • Rakha EA  et al. Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes. Clin Cancer Res 15:2302-10 (2009). Human . PubMed: 19318481
  • Rakha EA  et al. Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes. Clin Cancer Res 15:2302-10 (2009). Human . PubMed: 19318481
  • Albergaria A  et al. Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours. Breast Cancer Res 11:R40 (2009). IHC-P ; Human . PubMed: 19549328
  • Habashy HO  et al. Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance. Eur J Cancer 44:1541-51 (2008). Human . PubMed: 18538561

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"